PLAQUE PSORIASIS
Clinical trials for PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Psoriasis drug combo targets skin and cholesterol in one shot
Disease control Not yet recruitingThis study tests whether adding recaticimab to vunakizumab works better than vunakizumab alone for people with moderate to severe plaque psoriasis who also have high cholesterol. About 40 adults aged 18 to 75 will receive either the combination or a placebo injection. The main go…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
New psoriasis drug challenger enters final testing phase
Disease control Not yet recruitingThis study tests whether a new drug called QL2106 works as well as the approved drug Tremfya for people with moderate to severe plaque psoriasis. About 318 adults will receive either QL2106 or Tremfya by injection, and doctors will check how much their skin clears up after 16 wee…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a diabetes drug boost psoriasis treatment? new trial investigates
Disease control Not yet recruitingThis study tests whether adding metformin (a diabetes drug) to secukinumab (a standard psoriasis medication) works better than secukinumab alone for treating moderate-to-severe plaque psoriasis in overweight or obese Chinese adults. About 186 participants will receive either the …
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New psoriasis pill shows promise in Mid-Stage trial
Symptom relief Not yet recruitingThis study tests a new drug called HSK47388 in 220 adults with moderate-to-severe plaque psoriasis. Participants will receive either the drug or a placebo to see if it improves skin symptoms like redness, thickness, and scaling. The main goal is to measure how many people achieve…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 02:24 UTC